What it sells
Accelerating Histopathology for Cancer Research
Business model breakdown
Buyer: who owns the budget?
UnverifiedPrincipal investigators and lab/preclinical heads at biopharma, academic and research labs.
Trigger: what makes them buy now?
Need fast tissue processing and slide scanning/analysis, including GLP-compliant studies, without running an in-house histology lab.
Workflow: what inputs become what output?
Ship tissue specimens (dropbox/shipping kit), HistoWiz processes, stains and scans slides (as fast as 3 days), delivers digital whole-slide images in PathologyMap for viewing, sharing and pathologist consult or image analysis.
Economics: what it saves and how it charges
Fee-for-service lab work (histology, immunostaining, archiving, consults, image analysis) with a software platform layer; 1,500+ clients cited.
Distribution: how it reaches customers
Online order portal with signup and free trial, demo scheduling, referral/Champion program and content/webinars.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2016 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.